Production (Stage)
Krystal Biotech, Inc.
KRYS
$136.94
$4.323.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 616.85M | 597.52M | 588.32M | 559.61M | 538.26M |
| Total Receivables | 103.26M | 104.75M | 97.30M | 103.24M | 46.47M |
| Inventory | 29.94M | 26.51M | 18.58M | 12.18M | 11.04M |
| Prepaid Expenses | 16.75M | 13.27M | 8.96M | 7.75M | 6.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 766.80M | 742.05M | 713.16M | 682.77M | 602.25M |
|
|
|||||
| Total Current Assets | 766.80M | 742.05M | 713.16M | 682.77M | 602.25M |
| Net Property, Plant & Equipment | 158.93M | 161.45M | 163.06M | 165.47M | 166.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 218.00K | 231.00K | 203.00K | 126.00K | 196.00K |
| Total Assets | 1.07B | 1.06B | 982.32M | 917.66M | 853.30M |
|
|
|||||
| Total Accounts Payable | 2.67M | 4.99M | 5.58M | 5.43M | 5.36M |
| Total Accrued Expenses | 59.29M | 52.78M | 43.36M | 31.71M | 18.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.36M | 1.22M | 1.29M | 1.36M | 1.43M |
| Total Finance Division Other Current Liabilities | 16.16M | 43.02M | 39.30M | 33.36M | 22.54M |
| Total Other Current Liabilities | 16.16M | 43.02M | 39.30M | 33.36M | 22.54M |
| Total Current Liabilities | 79.49M | 102.00M | 89.53M | 71.85M | 47.59M |
|
|
|||||
| Total Current Liabilities | 79.49M | 102.00M | 89.53M | 71.85M | 47.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.30M | 6.04M | 6.18M | 6.33M | 6.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.95M | 1.42M | 761.00K | 588.00K | -- |
| Total Liabilities | 89.74M | 109.46M | 96.47M | 78.77M | 54.05M |
|
|
|||||
| Common Stock & APIC | 1.13B | 1.13B | 1.11B | 1.09B | 1.07B |
| Retained Earnings | -144.94M | -180.67M | -226.15M | -253.33M | -268.90M |
| Treasury Stock & Other | 390.00K | -190.00K | 1.51M | -634.00K | -299.00K |
| Total Common Equity | 984.67M | 946.38M | 885.85M | 838.89M | 799.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 984.67M | 946.38M | 885.85M | 838.89M | 799.24M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 984.67M | 946.38M | 885.85M | 838.89M | 799.24M |
|
|
|||||